Cancer evolution: the final frontier of precision medicine?

Ann Oncol. 2014 Mar;25(3):549-551. doi: 10.1093/annonc/mdu005.

Abstract

This editorial will review our current understanding of intratumour heterogeneity and cancer evolution and its potential impact on patient outcome and biomarker validation.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Evolution, Molecular*
  • Humans
  • Mutation
  • Neoplasms / genetics*